Keywords: GlaxoSmithKline, UK investment, Manufacturing sites, Budget plans, Patent box, Corporation tax

GlaxoSmithKline backs UK Budget plans, announcing £500 million investment

Article | 22 March 2012

Print This

Backing its support for UK Budget plans revealed yesterday, pharma giant GlaxoSmithKline (LSE: GSK) this morning announced that it will ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in